These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8494008)

  • 1. Have rational therapeutic principles emerged in treating hypertension in chronic renal failure?
    de Zeeuw D; Gansevoort RT; de Jong PE
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):108-12. PubMed ID: 8494008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension as a risk factor for progression of renal failure].
    Hilgers KF; Veelken R; Luft FC; Geiger H; Mann J
    Internist (Berl); 1992 Aug; 33 Suppl 1():S27-30. PubMed ID: 1428693
    [No Abstract]   [Full Text] [Related]  

  • 3. Insufficient therapeutic management of hypertensive patients with renal failure in France.
    P-Guérin A; Maumus-Robert S; Zin A
    Arch Cardiovasc Dis; 2008; 101(11-12):705-13. PubMed ID: 19059565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of hypertension in progression of chronic renal failure--therapeutic prospects].
    Wiecek A
    Pol Arch Med Wewn; 2000 Oct; 104(4):665-70. PubMed ID: 11392154
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Remission of chronic kidney diseases. A realistic goal?].
    Mayer G
    Wien Klin Wochenschr; 2003 Jul; 115(12):405-6. PubMed ID: 12918182
    [No Abstract]   [Full Text] [Related]  

  • 7. Composite renal endpoints: was ACCOMPLISH accomplished?
    Heerspink HL; de Zeeuw D
    Lancet; 2010 Apr; 375(9721):1140-2. PubMed ID: 20170949
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of the progression of chronic kidney failure].
    Teschner M; Bahner U; Heidland A
    Dtsch Med Wochenschr; 1987 Feb; 112(9):353-8. PubMed ID: 3545754
    [No Abstract]   [Full Text] [Related]  

  • 9. Are newer antihypertensive agents really more effective than traditional drugs in progressive renal disease?
    Ritz E; Fliser D; Keller H; Reisch C
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):76-80. PubMed ID: 2024679
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of enalapril on renal function in patients with severe chronic kidney disease.
    Vernaglione L
    Nephrol Dial Transplant; 2007 Feb; 22(2):665-6. PubMed ID: 16951420
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with the angiotensin II antagonist valsartan in patients with chronic renal failure and hypertension.
    Plum J; Bünten B; Németh R; Grabensee B
    Nephrol Dial Transplant; 1999; 14 Suppl 4():25-7. PubMed ID: 10463202
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of various antihypertensive agents on cardiovascular risk factors in patients with renal failure.
    Zarama M; Raij L
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):100-7. PubMed ID: 8494007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial hypertension in children with chronic renal insufficiency].
    Fossali E; Monti MC; Ruzza ML; Edefonti A
    Pediatr Med Chir; 1989; 11(3):247-63. PubMed ID: 2687817
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic theory of progressive renal disease: a 10-year update in brief review.
    Neuringer JR; Brenner BM
    Am J Kidney Dis; 1993 Jul; 22(1):98-104. PubMed ID: 8322801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapeutic blood pressure management in a chronic kidney disease patient.
    Salinitri F; Berlie H; Desai N
    AACN Adv Crit Care; 2009; 20(3):205-13; quiz 214-5. PubMed ID: 19638739
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Nakano N; Furukata S; Akashiba A; Minami J; Numabe A; Matsuoka H
    Clin Exp Hypertens; 2011; 33(6):366-72. PubMed ID: 21797795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perioperative hypotensive therapy of patients with chronic renal insufficiency].
    Shtutin SA
    Lik Sprava; 2002; (1):63-6. PubMed ID: 11944384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy in dialysed patients.
    Vendemia F; D'Amico G
    Contrib Nephrol; 1988; 61():161-70. PubMed ID: 3282779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renal effects of combined anti-hypertensive treatments].
    Gallieni M; Olivi L; Mezzina N; Cozzolino M; Cusi D
    Recenti Prog Med; 2010 Feb; 101(2):70-7. PubMed ID: 20433005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hypertension in the patient with chronic renal disease.
    Swartz CD; Kim KE
    Cardiovasc Clin; 1978; 9(1):263-72. PubMed ID: 667884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.